| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.77B | 56.66B | 74.72B | 69.36B | 60.28B | 58.00B |
| Gross Profit | 14.54B | 9.85B | 14.20B | 12.83B | 9.05B | 9.24B |
| EBITDA | 10.79B | 6.16B | 10.45B | 8.86B | 6.15B | 6.91B |
| Net Income | 5.06B | 3.26B | 4.86B | 4.35B | 3.08B | 3.41B |
Balance Sheet | ||||||
| Total Assets | 77.97B | 82.02B | 90.60B | 74.15B | 64.11B | 62.78B |
| Cash, Cash Equivalents and Short-Term Investments | 6.52B | 12.37B | 16.50B | 19.11B | 13.62B | 15.98B |
| Total Debt | 1.80B | 512.00M | 8.07B | 389.00M | 155.00M | 441.67M |
| Total Liabilities | 30.57B | 32.03B | 42.26B | 27.53B | 22.54B | 23.69B |
| Stockholders Equity | 40.21B | 42.84B | 40.48B | 39.70B | 35.51B | 33.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.66B | -5.16B | 7.06B | -615.00M | 10.84B |
| Operating Cash Flow | 0.00 | 10.94B | -2.65B | 8.84B | 495.00M | 11.92B |
| Investing Cash Flow | 0.00 | -4.09B | -2.46B | -1.54B | -711.00M | -1.19B |
| Financing Cash Flow | 0.00 | -10.98B | 2.50B | -1.80B | -2.15B | -3.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥45.23B | 10.32 | ― | 1.96% | 24.91% | 51.00% | |
73 Outperform | ¥41.20B | 8.82 | ― | 3.97% | -3.24% | 60.95% | |
67 Neutral | ¥47.68B | 10.50 | ― | 2.19% | 2.18% | 24.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥40.90B | 12.06 | ― | 5.38% | -24.18% | -32.34% | |
63 Neutral | ¥43.06B | 10.94 | ― | 3.53% | 6.68% | -6.70% | |
50 Neutral | ¥42.57B | 9.89 | 1.27% | 3.81% | 7.82% | 704.89% |